ALT
Altimmune
$2.05
−$0.07 (−3.3%)Oct 26, 2026
Key metrics
The numbers that frame ALT today
- Market cap
- $398.76M
- Gross margin
- 100%
- EV / Sales
- 11,950.1
- ROIC
- -30.4%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $2.02
- 52wk High
- $6.44
Growth
Revenue and earnings trend for ALT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ALT
Is Altimmune a good buy?
No. Altimmune has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Altimmune is selling at a very high price.
What is the market capitalization of ALT?
Altimmune's market capitalization is $398.76M.
What is the 52-week high for ALT stock?
The 52-week high for Altimmune is $6.44. The current close of $2.05 is 68.2% below that high.
What is the 52-week low for ALT stock?
The 52-week low for Altimmune is $2.02. The current close of $2.05 is 1.5% above that low.
Does ALT stock pay dividends?
Altimmune does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ALT?
Altimmune's Debt / Equity ratio is 0.07.